VEGFR2/CD309 anticorps (Internal Region)
Aperçu rapide pour VEGFR2/CD309 anticorps (Internal Region) (ABIN363476)
Antigène
Voir toutes VEGFR2/CD309 (VEGFR2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1200-1300, Internal Region
-
Specificité
- Reacts with human KDR 151 kDa protein
-
Réactivité croisée
- Souris, Rat (Rattus)
-
Réactivité croisée (Details)
- May cross reacts with mouse, rat and human proteins. Not other species tested.
-
Purification
- purified
-
Immunogène
- Synthetic peptide made to an internal region of the murine VEGFR2 protein sequence (between residues 1200-1300)
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- WB : 1/250 to 1/1 000 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Tris-glycine, NaCl 150 mM buffer, Sodium azide 0.05 %
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 4°C. Do not freeze.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Autre désignation
- Vascular Endothelial Growth Factor Receptor 2 / CD309
-
Pathways
- Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Antigène
-